Torrent Pharmaceuticals Limited (BOM: 500420)

Market Cap	1.16T
Revenue (ttm)	109.96B
Net Income (ttm)	17.35B
Shares Out	338.45M
EPS (ttm)	51.27
PE Ratio	66.83
Forward PE	51.84
Dividend	28.00 (0.82%)
Ex-Dividend Date	Jun 21, 2024

Volume	363
Open	3,345.00
Previous Close	3,426.80
Day's Range	3,345.00 - 3,490.75
52-Week Range	1,822.25 - 3,574.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Torrent Pharmaceuticals

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including cardiovascular, central nervous system, gastro-intestinal, and women healthcare; and dermatology, diabetology, pain management, gynecology, oncology, and anti-infective, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company...

• Industry: Pharmaceutical Preparations
• Founded: 1959
• Employees: 15,718
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500420

Financial Performance

In 2023, Torrent Pharmaceuticals's revenue was 107.28 billion, an increase of 11.51% compared to the previous year's 96.20 billion. Earnings were 16.56 billion, an increase of 33.02%.